A Glimpse of Zhongguancun Life Science Park
Zhongguancun Life Science Park, as an important support for the main platform of Beijing International Technology Innovation Center” consisting of Zhongguancun Science City, Huairou Science City, Changping Future Science City as well as Yizhuang Economic and Technological Development Zone, is a highland for the development of pharmaceutical and health industry that integrates four state-level functional zones, that is, Zhongguancun Independent Innovation Demonstration Zone, National Comprehensive Demonstration Zone for the Expansion and Opening-up of the Service Industry, Free Trade Pilot Zone, and the core area of high-level talents in Beijing. After 20 years of development, the Park has attracted multiple state-level research and development institutions to have their presence here, brought together a group of globally top scientists and hundreds of high-level talents. There are more than 600 innovative pharmaceutical enterprises and over 300 high-end talents, including 21 academicians, 4 scholars supported by the Cheung Kong Scholars Programme, 50+ personnel entitled to special allowance from the State Council, 7 academician workstations, 20+ post-doctoral research centers, 10+ national engineering research centers and key laboratories, 16 R&D centers at provincial and ministerial level, and nearly 3,000 sickbeds in the medical institutions, thus forming the trend of bringing together the whole industry chain including basic research, R&D pilot test, production and circulation, and terminal healthcare. It has been built into one of the parks with the most concentrated innovation resources in the field of life science in China, which is an innovation engine for the development of the pharmaceutical and health industry in Beijing.
300 +
High-end talents
600 +
Innovative pharmaceutical enterprises
7 +
Academician workstations
21 +
Post-doctoral research centers
10 +
Academician workstations
16
R&D centers at provincial and ministerial level
INDUSTRYGROUP
INNOVATIONPLATFORM
Beijing Zhongguancun Life Science Park Biomedicine Technology Incubation Co., Ltd. is a professional incubator specializing in the field of biomedicine. Since its establishment, it has received dozens of licensing and qualifications granted by the government. In addition, it undertakes work related to Overseas Students Pioneer Park at Beijing Zhongguancun Life Science Park and the IPR Public Service Workstation at Changping District Life Science Park, offering incubation service for more than 140 well-known startup companies in the industry, such as BeiGene, Crown Bioscience, BerryGenomics, Novogene, Sironax, Biocytogen, MyGenostics, etc.
The international incubator ATLATL, a high-end platform for the acceleration of innovation projects, which aligns with the standards of top international biopharmaceutical R&D centers, initiated by Dr. Zhu Pengcheng, focusing on key subdivisions and emerging technology fields such as cell and gene therapy, miRNA, gene editing and synthetic biology. By introducing professional research teams, it aims to build a base for double transformation in international cooperation on cutting-edge technology and the industrialization of R&D results. Recently, ATLATL, together with SEQUANTA, has set up a sequencing center to better serve customers and contribute to more unicorn companies in Beijing.
Bio2, built and officially put into operation in 2021, focusing on the needs of scientists and entrepreneurs, puts emphasis on the transformation of early results in life and health and business incubation. Relying on the combined advantages of “professional carrier platform + abundant funding channels + active interactive information base”, Bio2 provides start-up teams with ready-to-use shared office space and professional shared experimental sites. At present, nearly 30 potential projects with global leading technologies have been reserved, and 44 innovation-oriented enterprises such as Sironax, Neural Galaxy, Shuimu Biosciences, Pulmongene Ltd., and Simcere have settled here.
Changping Life Valley Marathon Digital Medical Incubator is China’s first digital medical business incubator jointly initiated by BC-TID, Zhongguancun Life Science Park and Marathon Venture Partners. With the vision of making investment for accelerating the new generation of digital medical entrepreneurs and promoting global digital medical industry-university-research innovation, the incubator will focus on the development direction of digital healthcare and smart healthcare, such as AI healthcare, medical robot, genomics, digital therapy, insurance technology, committed to making full cooperation with the world’s top parks, medical centers, scientific research institutions and other ecological partners.
2024-02-19
原研创新丨脑科所周景峰实验室:情境状态在眶额叶皮层中的动态与稳定编码
原研创新丨一石三鸟:北生所黄牛实验室利用反向共价对接筛选方法发现老药Entacapone的新靶标KEAP1
近日,中关村生命科学园内科研机构北生所黄牛实验室,在美国化学会ACS Pharmacology & Translational Science杂志上发表题为“Structure-Based Identification of Kelch-like ECH-associated Protein 1 as a Pharmacological Target of Electrophile Containing Catechol-O-methyltransferase Inhibitors”的文章。
减肥药未来趋势:诺和诺德与礼来谁能号令天下?
作为当今最炙手可热的药物,中关村生命科学园内企业诺和诺德的Wegovy(司美格鲁肽)和礼来的Zepbound(替尔泊肽)之间的直接较量代表着这个领域最高水平的抗衡。这两款GLP-1受体激动剂之间的华山论剑被视为肥胖症领域内最高的竞争级别。
服务赋能丨北京药品医疗器械创新服务站咨询安排(2024年2月18日——2月23日)
服务赋能丨北京药品医疗器械创新服务站咨询安排(2024年2月18日——2月23日)